Bioxcel Therapeutics is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.
Trademark Applications
Trademark applications show the products and services that Bioxcel Therapeutics is developing and marketing.
Bioxcel Therapeutics doesn't have any recent trademark applications, indicating Bioxcel Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
RELFINBI Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or symptoms associated with depression or other central nervous system disorders
09/08/2021
OMFILTO Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or symptoms associated with depression or other central nervous system disorders
09/08/2021
ZELTIGNA Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or symptoms associated with depression or other central nervous system disorders
09/08/2021
See all trademarks and details in the Full Report.
Market Share of Bioxcel Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Bioxcel Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Bioxcel Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Bioxcel Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.